PROMETA Treatment Details How long will I be treated? The initial phase of PROMETA treatment is administered over the course of 2-3 visits on consecutive days, depending on the substance(s) of dependence. In the case of cocaine or methamphetamine dependence (or dependence to both alcohol and stimulants), a second course of treatment over 2 visits to the facility on consecutive days takes place about three weeks after the initial treatment. In either case, this will be followed by 1 month of at-home prescription medications and nutritional supplements, along with after care, which is considered essential for maximizing success in recovery. How much does treatment using PROMETA cost? The cost of treatment with PROMETA depends on several factors, including the substance(s) of dependence and the location where the treatment is administered. The treatment is not currently reimbursed by insurance companies, so payment is made directly by the patient. What can I expect when I arrive for my treatment? Treatment will be administered at a hospital or physician practice, and overseen by a physician who has licensed the rights from Hythiam to use PROMETA. Prior to treatment, a comprehensive medical examination will be performed, along with urine and blood tests. Treatment then begins with the administration of prescription medications and nutrients over a period of 2–3 consecutive days. Am I treated as part of a group, or individually? Each patient receiving treatment with PROMETA begins treatment individually. After care following the treatment is considered an essential part of recovery, and can take place either in individual or group settings. Am I sedated during the treatments? PROMETA treatments are designed to minimize patient sedation. Some of the medications in the treatment plan may cause drowsiness. This should be discussed with your PROMETA treatment provider. Will I experience pain? While there may be mild discomfort from administering the medications, the PROMETA treatments are designed to ensure that the patient is as comfortable and alert as possible throughout the medically-supervised procedures. What do I do each day following treatment? In general, each medically-based treatment session typically lasts about 1 hour. Some patients may receive their treatments in a hospital, or "in-patient" setting. For these patients, the balance of time spent at the treatment facility or hospital is intended to ensure that the patient is well-rested and comfortable between the relatively short treatment periods. Some patients may require a third day of treatment, but it will be up to the treating physician to make this decision during the course of treatment. For patients receiving care in an "outpatient" facility, such as a physician's office or treatment center, their doctor may monitor them following each treatment session for a few hours. The patient would then be released to an accompanying person and return the following day for completion of their treatment. It is important to discuss your individual situation with your PROMETA-treating physician to ensure that you know what to expect during the treatment periods. What happens after the initial 2–3 visits are completed? Following the initial treatment, the PROMETA protocol provides medically supervised follow-up, including 1 month of prescription medications and nutrition supplements, plus enrollment in after care treatment (such as counseling or group support). Additionally, the PROMETA treatment protocol for cocaine or methamphetamine dependence includes a second medically supervised course of treatment given on 2 consecutive days, about 3 weeks after the initial treatment. Treatment providers will work with each patient to determine the after care plan that is right for him or her. Am I Right for PROMETA? Is treatment using PROMETA appropriate for my situation? Only a treating physician can determine whether treatment using PROMETA is right for an individual patient. PROMETA treatment may be appropriate for patients diagnosed with alcohol, cocaine, or methamphetamine dependencies, as well as addictions to combinations of these substances. Who is not appropriate for treatment using PROMETA? It is up to the PROMETA-treating physician to decide whether treatment with the medications administered as part of PROMETA is appropriate for any given patient. PROMETA is not designed to treat dependence on opiates, benzodiazepines (e.g. sedatives) or addictive substances other than alcohol, cocaine, or methamphetamine. PROMETA should not be administered in women who are or who plan to be pregnant or nursing during the course of PROMETA treatment. There may be other restrictions, including the taking of specific medications, which your treating physician will address. Other prescribing restrictions may apply. Your treating physician must determine if treatment using PROMETA is appropriate for you, depending on your medical condition and current medications Where to Find PROMETA My physician does not know about PROMETA. Where can I find more information about PROMETA? Because treatment using PROMETA can only be administered by professionals at a location licensed by Hythiam, physicians interested in learning more can contact Hythiam at (866) 321-6558 for information about signing the necessary confidentiality agreement and receiving more information about the PROMETA treatment methodologies. How can I find a treatment center in my area that licenses PROMETA from Hythiam®? For information regarding treatment locations that license PROMETA from Hythiam, call the PROMETA Helpline at (866) 321-6558, or look up PROMETA treatment locations near you. Does Hythiam sell the treatment directly to patients? No. PROMETA treatments are for use by physicians in locations with license rights from Hythiam to use PROMETA. Hythiam does not provide medical advice or medical treatment, and makes no claims about the effectiveness and suitability of treatment using PROMETA for any individual patient. Hythiam simply licenses the rights to use PROMETA to providers. Physicians must exercise their own professional judgment in recommending PROMETA for their patients. PROMETA | TREATMENT WITH PROMETA | 
